T. Rowe Price Associates
MXIM

T. Rowe Price Associates’s Maxim Integrated Products MXIM Stock Holding History

T. Rowe Price Associates’s Portfolio MXIM Stock Details MXIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,735,433
Closed -$394M – 3028
2021
Q2 		$394M Sell
3,735,433
-11,777,775
-76% -$1.15B 0.04% 388
2021
Q1 		$1.42B Sell
15,513,208
-10,334,578
-40% -$948M 0.14% 162
2020
Q4 		$2.29B Sell
25,847,786
-1,764,496
-6% -$139M 0.24% 89
2020
Q3 		$1.87B Buy
27,612,282
+525,488
+2% +$35.6M 0.22% 95
2020
Q2 		$1.64B Sell
27,086,794
-4,047,168
-13% -$225M 0.21% 100
2020
Q1 		$1.51B Buy
31,133,962
+2,338,850
+8% +$134M 0.24% 90
2019
Q4 		$1.77B Sell
28,795,112
-5,554,150
-16% -$323M 0.23% 98
2019
Q3 		$1.99B Sell
34,349,262
-3,331,419
-9% -$193M 0.28% 81
2019
Q2 		$2.25B Sell
37,680,681
-177,984
-0.5% -$10.1M 0.32% 68
2019
Q1 		$2.01B Sell
37,858,665
-16,349
-0% -$879K 0.3% 76
2018
Q4 		$1.93B Buy
37,875,014
+3,257,383
+9% +$170M 0.33% 64
2018
Q3 		$1.95B Buy
34,617,631
+2,358,773
+7% +$142M 0.28% 79
2018
Q2 		$1.89B Buy
32,258,858
+13,961,472
+76% +$813M 0.29% 76
2018
Q1 		$1.1B Buy
18,297,386
+18,140,209
+11,541% +$1.07B 0.18% 129
2017
Q4 		$8.22M Sell
157,177
-10,090
-6% -$524K ﹤0.01% 1369
2017
Q3 		$7.98M Buy
167,267
+634
+0.4% +$29.1K ﹤0.01% 1370
2017
Q2 		$7.48M Buy
166,633
+913
+0.6% +$41.9K ﹤0.01% 1359
2017
Q1 		$7.45M Buy
165,720
+1,153
+0.7% +$50.5K ﹤0.01% 1377
2016
Q4 		$6.35M Buy
164,567
+468
+0.3% +$18.4K ﹤0.01% 1389
2016
Q3 		$6.55M Buy
164,099
+250
+0.2% +$9.86K ﹤0.01% 1389
2016
Q2 		$5.85M Buy
163,849
+15,130
+10% +$555K ﹤0.01% 1378
2016
Q1 		$5.47M Buy
148,719
+20,715
+16% +$695K ﹤0.01% 1382
2015
Q4 		$4.86M Sell
128,004
-15,617
-11% -$597K ﹤0.01% 1423
2015
Q3 		$4.8M Hold
143,621
– – ﹤0.01% 1441
2015
Q2 		$4.97M Buy
143,621
+3,500
+2% +$120K ﹤0.01% 1481
2015
Q1 		$4.88M Buy
140,121
+5,200
+4% +$178K ﹤0.01% 1473
2014
Q4 		$4.3M Sell
134,921
-5,700
-4% -$168K ﹤0.01% 1483
2014
Q3 		$4.25M Buy
140,621
+13,700
+11% +$431K ﹤0.01% 1483
2014
Q2 		$4.29M Buy
126,921
+3,200
+3% +$107K ﹤0.01% 1475
2014
Q1 		$4.1M Sell
123,721
-2,900
-2% -$89.1K ﹤0.01% 1457
2013
Q4 		$3.53M Sell
126,621
-30,300
-19% -$876K ﹤0.01% 1465
2013
Q3 		$4.68M Buy
156,921
+5,100
+3% +$145K ﹤0.01% 1436
2013
Q2 		$4.22M Buy
+151,821
New +$4.6M ﹤0.01% 1434

Other funds holding MXIM

CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
RP
Rowlandmiller & Partners Atlanta, Georgia $549M AUM 36.2% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

T. Rowe Price Associates's MXIM Position: Q3 2021 in Review

T. Rowe Price Associates sold out of Maxim Integrated Products (MXIM) in Q3 2021, closing a stake of 3,735,433 shares — an estimated $394M sold.

T. Rowe Price Associates first reported a position in MXIM in Q2 2013 and held it in 33 quarters. The position peaked at $2.29B in Q4 2020. 3 funds tracked by Wall St. Rank hold MXIM as of Q3 2021.

  • T. Rowe Price Associates reported no remaining Maxim Integrated Products position as of Q3 2021 after selling out during the quarter.
  • T. Rowe Price Associates sold 3,735,433 Maxim Integrated Products shares in Q3 2021, an estimated $394M.
  • T. Rowe Price Associates first reported a position in Maxim Integrated Products in Q2 2013 and held it in 33 quarters.
  • T. Rowe Price Associates's Maxim Integrated Products position peaked at $2.29B in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Maxim Integrated Products as of Q3 2021.

Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.